{
    "eid": "2-s2.0-85131551698",
    "title": "Immunogenicity and Reactogenicity of mRNA BNT162b2 COVID-19 Vaccine among Thai Adolescents with Chronic Diseases",
    "cover-date": "2022-06-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Immunology",
            "@code": "2403",
            "@abbrev": "IMMU"
        },
        {
            "@_fa": "true",
            "$": "Pharmacology",
            "@code": "3004",
            "@abbrev": "PHAR"
        },
        {
            "@_fa": "true",
            "$": "Drug Discovery",
            "@code": "3002",
            "@abbrev": "PHAR"
        },
        {
            "@_fa": "true",
            "$": "Infectious Diseases",
            "@code": "2725",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Pharmacology (medical)",
            "@code": "2736",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [
        "adolescent",
        "BNT162b2",
        "immunocompromised",
        "SARS-CoV-2 antibody"
    ],
    "authors": [
        "Napaporn Chantasrisawad",
        "Thanyawee Puthanakit",
        "Auchara Tangsathapornpong",
        "Chonnamet Techasaensiri",
        "Wanatpreeya Phongsamart",
        "Detchvijitr Suwanpakdee",
        "Peera Jaruampornpan",
        "Jiratchaya Sophonphan",
        "Piyarat Suntarattiwong",
        "Tawee Chotpitayasunondh"
    ],
    "citedby-count": 9,
    "ref-count": 36,
    "ref-list": [
        "COVID-19 in 7780 pediatric patients: A systematic review",
        "Clinical out-comes of pediatric COVID-19 in a tertiary care center in Bangkok, Thailand",
        "Incidence of multisystem inflammatory syndrome in children among US persons infected with SARS-CoV-2",
        "Review: Mental health impacts of the COVID-19 pandemic on children and youth-a systematic review",
        "Impact of COVID-19 and lockdown on mental health of children and adolescents: A narrative review with recommendations",
        "Safety, immunogenicity, and efficacy of the BNT162b2 COVID-19 vaccine in adolescents",
        "Effect of immunosuppression on the immunogenicity of mRNA vaccines to SARS-CoV-2: A prospective cohort study",
        "Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in adult patients with autoimmune inflammatory rheumatic diseases and in the general population: A multicentre study",
        "Antibody response to SARS-CoV-2 mRNA vaccine among kidney transplant recipients: A prospective cohort study",
        "Antibody response to 2-dose SARS-CoV-2 mRNA vaccine series in solid organ transplant recipients",
        "The advisory committee on immunization practices\u2019 interim recommendations for additional primary and booster doses of COVID-19 vaccines\u2014United States, 2021",
        "Risk factors for severe COVID-19 in children",
        "Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection",
        "A SARS-CoV-2 surrogate virus neutralization test based on antibody-mediated blockage of ACE2\u2013spike protein\u2013protein interaction",
        "Comparative immunogenicity of BNT162b2 mRNA vaccine with natural SARS-CoV-2 infec-tion",
        "High antibody response to two-dose SARS-CoV-2 messenger RNA vaccination in patients with rheumatic and musculoskeletal dis-eases",
        "Reduced humoral response to mRNA SARS-CoV-2 BNT162b2 vaccine in kidney transplant recipients without prior exposure to the virus",
        "Coronavirus disease 2019 messenger RNA vaccine immunogenicity in immunosuppressed individuals",
        "Antibody response after second BNT162b2 dose in allogeneic HSCT recipients",
        "Effectiveness of 2-dose vaccination with mRNA COVID-19 vaccines against COVID-19-associated hospitalizations among im-munocompromised adults\u2014Nine states, January-September 2021",
        "Immunologic response of mRNA SARS-CoV-2 vaccination in adolescent kidney transplant recipients",
        "Adaptive immunity and neutralizing antibodies against SARS-CoV-2 variants of concern following vaccination in patients with cancer: The CAPTURE study",
        "Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in people living with HIV-1",
        "Safety and Efficacy of the BNT162b2 mRNA Covid-19 vaccine",
        "Waning immune humoral response to BNT162b2 Covid-19 vaccine over 6 months",
        "COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses",
        "Durability and cross-reactivity of SARS-CoV-2 mRNA vaccine in adolescent children",
        "Association between reactogenicity and immunogenicity after vaccination with BNT162b2",
        "Adverse effects and antibody titers in response to the BNT162b2 mRNA COVID-19 vaccine in a prospective study of healthcare workers",
        "Age-dependent immune response to the Biontech/Pfizer BNT162b2 Coronavirus Disease 2019 vaccination"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60002620",
            "affilname": "Faculty of Medicine, Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60199575",
            "affilname": "Siriraj Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60199575",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60022183",
            "affilname": "King Chulalongkorn Memorial Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022183",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60015887",
            "affilname": "Faculty of Medicine Ramathibodi Hospital, Mahidol University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60015887",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Pathum Thani",
            "@id": "60013939",
            "affilname": "Faculty of Medicine, Thammasat University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60013939",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Pathum Thani",
            "@id": "60011947",
            "affilname": "Thailand National Center for Genetic Engineering and Biotechnology",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60011947",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60010778",
            "affilname": "Queen Sirikit National Institute of Child Health",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60010778",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60006964",
            "affilname": "Phramongkutklao College of Medicine",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60006964",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": [
        "National Vaccine Institute, Thailand"
    ]
}